Mon Jan 27 13:20:00 UTC 2025: ## Merck & Co. (MRK) Among Top Dow Stocks, But AI Presents Stronger Potential: Analysis
**New York, NY** – A recent Insider Monkey analysis ranks Merck & Co., Inc. (NYSE:MRK) as a top 10 Dow stock to buy, but suggests that Artificial Intelligence (AI) stocks offer potentially higher and faster returns. The analysis, which identifies the 12 best Dow stocks based on Q3 2024 hedge fund holdings, highlights the strong performance of the Dow Jones Industrial Average (DJIA) in 2024 (over 16% return), although it lagged behind the broader market’s 25% gain.
The report notes that while the Dow’s historically strong performance stems from its stable, dividend-paying blue-chip companies, the current market is heavily influenced by the surge in tech stocks, particularly those involved in AI. The rise is attributed to factors such as President Trump’s AI initiatives and the significant growth of the AI market. The Nasdaq Composite, heavily weighted in tech, returned nearly 30% in 2024. The US economy is projected to perform better in 2025, potentially fueling mergers and acquisitions activity.
Merck’s success is attributed to its expanding drug portfolio (projected revenue exceeding $50 billion), driven by its successful anti-cancer drug, Keytruda, and the acquisition of Acceleron. The company is also involved in promising collaborations, such as with Gilead Sciences on HIV treatment. However, despite its strong performance, the analysis concludes that AI stocks currently offer more compelling investment opportunities.
The Insider Monkey report, which uses a strategy that has yielded a 275% return since 2014, suggests investors seeking high-growth potential should prioritize AI stocks over even strong Dow components like MRK. Readers interested in learning more about promising, undervalued AI stocks are directed to a separate Insider Monkey report.
First Piper 